Ozempic is FDA-approved for the management of type 2 diabetes, while Wegovy is FDA-approved specifically for chronic weight management in adults with obesity
Circana Nov 10, 2025 4 min read Updated: Nov 21, 2025 If the GLP-1 story over the past couple of years was the strong interest among consumers seeking to lose weight and manage their health and well-being, the latest insights from Circana reveal that the greater availability of GLP-1s has ushered in notable changes in diets, lifestyles, and spending
Overall, these data do tentatively support the possibility that biased GLP1 agonists might be associated with a lower rate of nausea than standard agents, although GLP1 agonists displaying a more extreme level of bias (e.g., TTP273) might be less effective for weight loss
This can translate into improved stamina, cognitive clarity, and recovery for plant-based individuals